Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study

• Sponsor: Zhe Fan (Other)
• Overall Status: Completed
• CT.gov ID: NCT06087887
• Collaborator: (none)
• Enrollment: 8,163
• Location: 1
• Actual Duration (Months): 9
• Patients Per Site Per Month: 910.1

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about in small bowel adenocarcinoma patients. The main question it aims to answer is the association between tumor size and prognosis in patients with small bowel adenocarcinoma. Participants will be compared for the relationship between tumor size and prognosis.

Condition or Disease	Intervention/Treatment	Phase
Prognosis	Other: no interventions

Study Design

• Study Type: Observational
• Actual Enrollment: 8163 participants
• Observational Model: Other
• Time Perspective: Retrospective
• Official Title: Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study
• Actual Study Start Date: Jan 1, 2023
• Actual Primary Completion Date: Sep 1, 2023
• Actual Study Completion Date: Oct 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
tumor size 0-1cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 0-1 cm.	Other: no interventions; no interventions
tumor size 1-2 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 1-2 cm.
tumor size 2-3 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 2-3 cm.
tumor size 3-4 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 3-4 cm.
tumor size 4-5 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 4-5 cm.
tumor size 5-6 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 5-6 cm.
tumor size 6-7 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 6-7 cm.
tumor size 7-8 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 7-8 cm.
tumor size 8-9 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 8-9 cm.
tumor size 9-10 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of 9-10 cm.
tumor size >10 cm No intervention. Select small bowel adenocarcinoma patients with tumor size of >10 cm.

Outcome Measures

Primary Outcome Measures

1. Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study [2024.9.1]

   We will study the relationship between tumor size and prognosis in small bowel adenocarcinoma patients in the SEER database

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

1. pathology confirmed as SBA;

2. received surgery and complete postoperative follow-up data;

3. histology type code 8140-8380.

Exclusion Criteria:

Cases with unknown tumor location, size, TNM staging, race, and degree of differentiation were excluded. Finally, 8,163 eligible patients were included in the analysis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Dalian Third People's Hospital Affiliated to Dalian Medical University	Dalian	Liaoning	China

Sponsors and Collaborators

• Zhe Fan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Zhe Fan, docter, The Third Peoples Hospital of Dalian
• ClinicalTrials.gov Identifier: NCT06087887
• Other Study ID Numbers: ThirdPHDalian
• First Posted: Oct 18, 2023
• Last Update Posted: Oct 18, 2023
• Last Verified: Oct 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Yes
• Plan to Share IPD: Yes
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Adenocarcinoma

Study Results

No Results Posted as of Oct 18, 2023